NeuroPace, Inc. (Nasdaq: NPCE), a medical device company focused on transforming the lives of people living with epilepsy, ...
People with epilepsy are at risk for hypertension, atrial fibrillation, and hyperlipidemia; they also have an elevated risk ...
NeuroPace, Inc. (Nasdaq: NPCE), a medical device company focused on transforming the lives of people living with epilepsy, ...
The Neurology Advisor Team spoke with Shilpa Reddy, MD, MMHC at AES 2025 in Atlanta, Georgia. Neurology Advisor: “Can you describe your work in neuromodulation?” ...
Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into ...
Children referred to a first seizure clinic (FSC) see a neurologist epilepsy specialist within one week, according to a study ...
Children referred to a first seizure clinic (FSC) see a neurologist epilepsy specialist within one week, according to a study ...
Xenon Pharmaceuticals Inc. ( XENE) Discusses Latest Phase III Updates for Azetukalner in Epilepsy and Commercial Launch Preparation December 10, 2025 10:00 AM EST ...
A New York accountant alleges her employer mishandled her epilepsy and medical leave, then terminated her after she sought ...
NeuroPace (NPCE) announced the presentation at the American Epilepsy Society meeting of preliminary 18-month safety and effectiveness results from ...
Collection of eight posters include analyses of data from studies of diazepam nasal spray in treatment of episodes of ...
Detailed price information for Praxis Precision Medicines Inc (PRAX-Q) from The Globe and Mail including charting and trades.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results